Screening close family for type 1 diabetes risk
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study screens close family members of people with type 1 diabetes for early signs of the condition. A simple blood test looks for special markers (autoantibodies) that can show if the immune system is starting to attack the pancreas. Finding these markers early may help doctors prevent or delay the onset of diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between the ages of 2 and 45.
- Have a parent, sibling, or child with type 1 diabetes.
- Not have any form of diabetes yourself.
- Never have taken insulin or diabetes pills.
- Not be taking strong immune-suppressing medications (inhaled or skin creams are okay).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study screens high-risk children for early signs of type 1 diabetes by testing relatives who already have the condition. It aims to catch diabetes early so treatment can start sooner.
This study screens brothers, sisters, and children of people with type 1 diabetes to find early signs of the disease before symptoms appear. The goal is to catch it early and offer monitoring or future prevention options.
This study tests whether sitagliptin can delay or prevent type 1 diabetes in people who have a close family member with type 1 diabetes and early “at-risk” blood test results. It focuses on relatives who have early immune markers and abnormal sugar testing, but are not yet diagnosed with type 1 diabetes.
This trial is looking for children with newly diagnosed type 1 diabetes to study how to detect the condition earlier. It focuses on kids who have already reached the stage where symptoms appear, to improve understanding of the disease.
This study tests whether a program of diet and activity advice for families can lower the risk of type 1 diabetes in infants who have a higher genetic chance of developing it. It aims to find simple, everyday ways to help protect your child.
This study screens very young infants (under 6 weeks old) to find those at high risk for type 1 diabetes. The goal is to identify babies who may be able to join future prevention trials.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.